Our Pipeline

Della Terra’s product portfolio focuses on plant and fungi-derived pharmaceuticals. We are continually researching and developing new pharmaceutical medicines based on botanical-derived compounds.

Pharmaceutical

Candidate
Pre-Clinical
Phase 1
Phase 2
Phase 3
Status

NPI - 003

Plant-derived alkaloid

Opiod Use Disorder

Complete
Complete
Planned

Phase 1 study is complete

NPI - 102

plant-derived cannabinoid

Complete

Pre-Clinical study complete

NPI - 101

plant-derived cannabinoid

Complete

Pre-Clinical study complete

NPI - 003

Plant-derived alkaloid

Opiod Use Disorder

Pre-Clinical
Phase 1
Phase 2
Phase 3

Phase 1 study complete. Phase 2 study planned.

NPI - 102

plant-derived cannabinoid

Pre-Clinical
Phase 1
Phase 2
Phase 3

Pre-Clinical study complete

NPI - 101

plant-derived cannabinoid

Pre-Clinical
Phase 1
Phase 2
Phase 3

Pre-Clinical study complete

Dietary Supplements

NDI
CMC
Non-Clinical
Regulatory Submission
Commercialization
Status

NPI - 001

Leaf Powder

Energy / Fatigue & Pain

Complete
In Progress

Preparing for NDIN Submission

NPI - 002

Extract Powder

Energy / Fatigue & Pain

In Progress

NPI - 004

Extract Solution

Energy / Fatigue & Pain

In Progress

NPI - 105

Full Spectrum Fiber

Planned

NPI - 107

Full Spectrum Fiber

Planned

NPI - 001

Leaf Powder

Energy / Fatigue & Pain

CMC
Non-Clinical
Regulatory Submission
Commercialization

Preparing for NDIN Submission

NPI - 002

Extract Powder

Energy / Fatigue & Pain

CMC
Non-Clinical
Regulatory Submission
Commercialization

CMC in Progress

NPI - 004

Extract Solution

Energy / Fatigue & Pain

CMC
Non-Clinical
Regulatory Submission
Commercialization

CMC in Progress

NPI - 105

Full Spectrum Fiber

CMC
Non-Clinical
Regulatory Submission
Commercialization

CMC Planned

NPI - 107

Full Spectrum Fiber

CMC
Non-Clinical
Regulatory Submission
Commercialization

CMC Planned

Our Partnerships

Della Terra Pharmaceuticals continually seeks scientific partners to strengthen our portfolio and advance our mission. We actively seek opportunities to collaborate with other companies, academia, patient advocacy groups, and industry stakeholders to develop and commercialize new products or license existing assets.

Let’s Connect

Get in Touch

Contact Us